No definition available.
Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)
C3_BRAIN_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
1977 |
4. Check minimum number of eventsNone |
1977 |
5. Include endpointsNone |
1977 |
6. Filter based on genotype QC (FinnGen only) |
1977 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1977 | 893 | 1084 |
| Unadjusted period prevalence (%) | 0.40 | 0.30 | 0.48 |
| Median age at first event (years) | 58.69 | 55.60 | 61.23 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1136
- Matched controls
- 11359
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
42.9
323.0
657
351
L01AX03
ATC
temozolomide; systemic
+∞
323.0
605
*
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
793.3
323.0
338
6
A03FA01
ATC
metoclopramide; systemic, rectal
18.1
323.0
594
648
H02AB02
ATC
dexamethasone; systemic
912.9
323.0
851
37
WF002
NOMESCO Finland
Radical radiotherapy
2540.0
323.0
344
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
95.8
323.0
408
66
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
41.3
323.0
570
270
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
1519.9
323.0
711
12
N03AX14
ATC
levetiracetam; systemic
106.0
323.0
511
87
130
Kela drug reimbursment
Malignant tumour
+∞
323.0
712
*
A04AA02
ATC
granisetron; systemic, transdermal
3542.8
323.0
415
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
1817.0
297.3
276
*
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
+∞
289.2
265
*
ZXC95
NOMESCO Finland
Use of surgical navigator
119.8
259.1
274
30
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
40.5
254.6
323
110
Z51.5
ICD-10 Finland
Palliative care
65.1
244.1
281
57
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
1291.0
223.7
211
*
XX3DW
NOMESCO Finland
Time consuming IT work
23.2
223.0
333
199
C71.20
ICD-10 Finland
Malignant tumor in temporal lobe without histology
+∞
222.3
206
*
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
+∞
221.2
205
*
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
853.9
220.7
210
*
A04AA01
ATC
ondansetron; systemic, rectal
46.4
218.1
268
75
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
50.0
210.0
254
65
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
1172.6
205.8
195
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
40.5
204.6
259
82
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
590.6
204.6
197
*
C71.11
ICD-10 Finland
Malignant tumor of frontal lobe grade II glioma
+∞
191.1
178
*
C71.23
ICD-10 Finland
Malignant tumor of temporal lobe grade IV glioma
+∞
180.1
168
*
AA1AD
NOMESCO Finland
CT of head and brain
6.8
178.8
589
1544
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
2046.2
177.9
168
*
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
1979.9
173.5
164
*
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
906.9
163.9
157
*
C71.13
ICD-10 Finland
Malignant tumor of frontal lobe grade IV glioma
+∞
163.5
153
*
C71.1
ICD-10 Finland
Malignant neoplasm: Frontal lobe
+∞
151.5
142
*
N03AF02
ATC
oxcarbazepine; oral
20.2
148.4
230
141
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
527.9
143.7
140
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
6.7
139.4
420
910
C71.2
ICD-10 Finland
Malignant neoplasm: Temporal lobe
+∞
137.3
129
*
C71.12
ICD-10 Finland
Malignant tumor of frontal lobe grade III glioma
+∞
135.1
127
*
9440/3-C71.9
ICD-O-3
Glioblastoma, NOS, of brain, NOS
+∞
134.0
126
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
127.5
120
*
N03AX18
ATC
lacosamide; systemic
93.3
120.1
132
16
ZXC40
NOMESCO Finland
Use of ultrasound
104.7
119.9
130
14
R56.8
ICD-10 Finland
Other and unspecified convulsions
11.1
115.6
234
260
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
252.9
112.9
114
5
C71.30
ICD-10 Finland
Malignant tumor in parietal lobe without histology
+∞
112.4
106
*
C71.21
ICD-10 Finland
Malignant tumor of temporal lobe grade II glioma
+∞
110.2
104
*
9440/3-C71.2
ICD-O-3
Glioblastoma, NOS, of temporal lobe
+∞
108.0
102
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
385.2
107.2
106
*
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
+∞
104.8
99
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.4
103.5
505
1762
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
7.5
103.1
268
448
AA1BD
NOMESCO Finland
Extensive CT of head and brain
29.2
101.7
139
54
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
100.5
95
*
XA800
NOMESCO Finland
Neuropsychological investigation
11.3
98.7
196
206
WX882
NOMESCO Finland
High dependency care
17.6
98.5
159
104
C71.22
ICD-10 Finland
Malignant tumor of temporal lobe grade III glioma
+∞
96.2
91
*
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
22.4
96.0
142
72
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
94.1
89
*
C71.33
ICD-10 Finland
Malignant tumor of parietal lobe grade IV glioma
+∞
94.1
89
*
9440/3-C71.1
ICD-O-3
Glioblastoma, NOS, of frontal lobe
+∞
90.8
86
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
89.8
85
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
9.5
88.3
193
240
G40.9
ICD-10 Finland
Epilepsy, unspecified
12.6
88.0
164
150
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
240.9
87.7
89
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
834.4
80.4
78
*
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
47.5
78.8
96
22
A02BC02
ATC
pantoprazole; systemic
3.5
78.1
841
5133
N74
ICPC
Malignant neoplasm nervous system
+∞
78.0
74
*
N02AA05
ATC
oxycodone; systemic
5.6
77.3
250
541
9680/3-C71.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of brain, NOS
+∞
76.9
73
*
C71.29
ICD-10 Finland
Malignant tumor in temporal lobe other or unspecified histology
+∞
74.8
71
*
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
33.0
73.6
97
32
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
26.2
73.4
103
43
N03AB02
ATC
phenytoin; systemic
30.5
72.9
98
35
C71.00
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles without histology
+∞
72.7
69
*
WF004
NOMESCO Finland
Palliative radiotherapy
742.9
71.9
70
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
18.9
70.6
110
64
WX402
NOMESCO Finland
General anaesthesia
4.6
69.9
280
757
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
68.4
65
*
C71.19
ICD-10 Finland
Malignant tumor of frontal lobe other or unspecified histology
+∞
68.4
65
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
351.9
67.2
67
*
AAA10
NOMESCO Finland
Biopsy through craniotomy
+∞
66.3
63
*
C71.3
ICD-10 Finland
Malignant neoplasm: Parietal lobe
+∞
65.2
62
*
WZC30
NOMESCO Finland
Teaching
5.2
64.9
222
504
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.9
64.5
321
1053
JN4BD
NOMESCO Finland
Extensive body CT
8.0
63.0
151
214
9380/3-C71.9
ICD-O-3
Glioma, malignant of brain, NOS
+∞
61.0
58
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
324.4
60.9
61
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
20.7
59.8
90
47
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
28.9
59.6
81
30
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
130.9
58.4
62
5
ZXM40
NOMESCO Finland
Use of fluorescent substance
+∞
57.8
55
*
L03AA02
ATC
filgrastim; parenteral
128.7
57.4
61
5
G40.10
ICD-10 Finland
Simple partial seizures
33.3
57.2
75
24
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
122.0
54.3
58
5
WX408
NOMESCO Finland
General anesthesy, balanced
3.1
53.2
372
1547
C71.83
ICD-10 Finland
Overall malignant tumor of the brain grade IV glioma
+∞
52.5
50
*
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
36.8
51.6
66
19
9400/3-C71.9
ICD-O-3
Astrocytoma, NOS, of brain, NOS
+∞
50.4
48
*
C71.31
ICD-10 Finland
Malignant tumor of the parietal lobe grand II glioma
+∞
50.4
48
*
9440/3-C71.3
ICD-O-3
Glioblastoma, NOS, of parietal lobe
+∞
49.3
47
*
9400/3-C71.1
ICD-O-3
Astrocytoma, NOS, of frontal lobe
+∞
48.3
46
*
A79
ICPC
Malignancy NOS
+∞
48.3
46
*
N05BA09
ATC
clobazam; oral
41.4
47.4
59
15
C71.9
ICD-10 Finland
Malignant neoplasm: Brain, unspecified
+∞
47.2
45
*
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
25.4
46.3
65
27
8000/3-C71.9
ICD-O-3
Neoplasm, malignant of brain, NOS
+∞
46.1
44
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
46.1
44
*
N03AF01
ATC
carbamazepine; oral, rectal
6.0
45.7
133
244
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
45.1
43
*
C71.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of brain
+∞
44.0
42
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
228.5
43.2
44
*
9450/3-C71.1
ICD-O-3
Oligodendroglioma, NOS, of frontal lobe
+∞
43.0
41
*
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
14.6
42.9
73
53
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
41.9
40
*
C71.32
ICD-10 Finland
Malignant tumor of parietal lobe grade III glioma
+∞
41.9
40
*
A28
ICPC
Limited function/disability NOS
3.4
40.7
227
783
H53.4
ICD-10 Finland
Visual field defects
9.5
39.5
83
93
H02AB09
ATC
hydrocortisone; systemic
9.7
39.5
82
90
N76
ICPC
Neoplasm nervous system unspecified
400.5
39.3
39
*
N03AG01
ATC
valproic acid; systemic, rectal
4.6
39.1
145
349
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
16.6
39.0
63
40
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
38.8
37
*
N05CD08
ATC
midazolam; nasal, systemic
8.7
38.3
85
105
C71.40
ICD-10 Finland
Malignant tumor of the occipital lobe without histology
+∞
37.7
36
*
L03AA13
ATC
pegfilgrastim; parenteral
379.0
37.2
37
*
WX872
NOMESCO Finland
Intensive care
5.1
37.1
123
262
WW500
NOMESCO Finland
Blood transfusion
12.9
36.8
66
54
TPH04
NOMESCO Finland
Cathetrisation of vein
2.8
36.8
284
1210
C71.80
ICD-10 Finland
Overall malignant tumor of the brain without histology
+∞
36.6
35
*
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
30.6
35.4
47
16
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.0
34.3
226
868
R90.0
ICD-10 Finland
Intracranial space-occupying lesion
123.7
33.9
36
*
C71.01
ICD-10 Finland
Malignant tumor of cerebellum except lobes and ventricles grade II glioma
+∞
33.5
32
*
C71.93
ICD-10 Finland
Malignant tumor in an unspecified localization in the brain grade IV glioma
+∞
33.5
32
*
R4110
NOMESCO Finland
Physiotherapy
2.5
33.2
326
1584
183
Kela drug reimbursment
Lamotrigin and topiramate
19.3
32.9
50
27
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
175.0
32.9
34
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
120.2
32.8
35
*
TPH07
NOMESCO Finland
Cathetrisation of artery
3.8
32.5
148
429
C71.39
ICD-10 Finland
Malignant tumor of parietal lobe other or unspecified histology
+∞
32.4
31
*
TAB00
NOMESCO Finland
Lumbar puncture
5.3
31.9
101
204
C71.43
ICD-10 Finland
Malignant tumor of the occipital lobe grade IV glioma
+∞
31.4
30
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
321.1
31.0
31
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
321.1
31.0
31
*
N05CF01
ATC
zopiclone; oral
2.2
30.4
393
2170
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
30.3
29
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
+∞
30.3
29
*
WX110
NOMESCO Finland
Local anesthesy
2.1
29.8
774
5731
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
29.6
214
866
R4150
NOMESCO Finland
Neuropsychological rehabilitation
19.8
29.3
44
23
9450/3-C71.9
ICD-O-3
Oligodendroglioma, NOS, of brain, NOS
+∞
29.3
28
*
115
Kela drug reimbursment
Breast cancer
+∞
28.2
27
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
288.1
27.9
28
*
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
43.7
27.8
34
8
JN4AD
NOMESCO Finland
Body CT examination
6.5
27.4
73
119
WX704
NOMESCO Finland
Intubation
3.8
26.5
120
345
B01AB10
ATC
tinzaparin; parenteral
5.0
26.4
88
188
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
26.1
25
*
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
16.9
25.9
41
25
D70.82
ICD-10 Finland
Drug-induced neutropenia
33.9
25.6
33
10
R4120
NOMESCO Finland
Occupational therapy
3.9
25.3
110
305
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
25.1
24
*
9401/3-C71.1
ICD-O-3
Astrocytoma, anaplastic, NOS, of frontal lobe
+∞
24.0
23
*
C71.03
ICD-10 Finland
Malignant tumor of cerebellum except lobes and ventricles grade IV glioma
+∞
24.0
23
*
A98
ICPC
Health maint/preventive medicine
0.5
23.7
836
9745
G41.9
ICD-10 Finland
Status epilepticus, unspecified
20.6
23.1
34
17
G91.1
ICD-10 Finland
Obstructive hydrocephalus
33.0
22.5
29
9
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
21.9
21
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
21.9
21
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
21.9
21
*
9400/3-C71.2
ICD-O-3
Astrocytoma, NOS, of temporal lobe
+∞
21.9
21
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
224.0
21.7
22
*
AA5FG
NOMESCO Finland
Functional MRI examination of brain with high intensity magnet
117.2
21.6
23
*
PJA12
NOMESCO Finland
Sentinel node biopsy
117.2
21.6
23
*
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
13.6
21.6
37
28
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
10.3
21.4
42
42
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
27.0
21.4
29
11
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
23.6
21.3
30
13
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
7.4
21.2
51
72
C71.82
ICD-10 Finland
Overall malignant tumor of the brain grade III glioma
+∞
20.9
20
*
9451/3-C71.1
ICD-O-3
Oligodendroglioma, anaplastic, NOS, of frontal lobe
+∞
20.9
20
*
C71.89
ICD-10 Finland
Overall malignant tumor of the brain other or unspecified histology
+∞
20.9
20
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
20.9
20
*
XF400
NOMESCO Finland
ECG with 12 standard connections
2.3
20.4
210
1014
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
9.6
20.2
41
44
B01AB05
ATC
enoxaparin; parenteral
2.0
20.1
294
1658
TPX10
NOMESCO Finland
Implantation of vascular injection port
8.4
20.1
44
54
C71.70
ICD-10 Finland
Malignant tumor of the brainstem without histology
+∞
19.8
19
*
C71
ICD-10 Finland
Malignant neoplasm of brain
+∞
19.8
19
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
19.8
19
*
9440/3-C71.0
ICD-O-3
Glioblastoma, NOS, of cerebrum
+∞
19.8
19
*
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
203.3
19.6
20
*
9401/3-C71.9
ICD-O-3
Astrocytoma, anaplastic, NOS, of brain, NOS
+∞
18.8
18
*
PA7ST
NOMESCO Finland
Extensive medical infusion to cerebral artery
+∞
18.8
18
*
C71.4
ICD-10 Finland
Malignant neoplasm: Occipital lobe
+∞
18.8
18
*
C71.60
ICD-10 Finland
Malignant tumor of cerebellum without histology
+∞
18.8
18
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
192.9
18.6
19
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.8
18.5
123
464
D69.5
ICD-10 Finland
Secondary thrombocytopenia
53.4
18.0
21
*
C71.65
ICD-10 Finland
Malignant tumor of the cerebellum primary neuroectodermal tumor
+∞
17.7
17
*
9401/3-C71.2
ICD-O-3
Astrocytoma, anaplastic, NOS, of temporal lobe
+∞
17.7
17
*
C71.0
ICD-10 Finland
Malignant neoplasm: Cerebrum, except lobes and ventricles
+∞
17.7
17
*
R47.0
ICD-10 Finland
Dysphasia and aphasia
10.3
17.5
34
34
JN4CD
NOMESCO Finland
Very extensive body CT
7.2
17.5
42
60
WX725
NOMESCO Finland
Noninvasive ventilation
3.8
17.3
74
203
N05BA04
ATC
oxazepam; oral
1.9
16.9
278
1625
R4130
NOMESCO Finland
Speech therapy
5.6
16.8
49
91
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
16.7
16
*
C71.91
ICD-10 Finland
Malignant tumor in unspecified location in the brain grade II glioma
+∞
16.7
16
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
16.1
433
2975
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
48.2
16.0
19
*
N03AX22
ATC
perampanel; oral
60.9
15.8
18
*
N03AX23
ATC
brivaracetam; systemic
33.9
15.8
20
6
C71.02
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles grade III glioma
+∞
15.7
15
*
C71.81
ICD-10 Finland
Overall malignant tumor of the brain grade II glioma
+∞
15.7
15
*
G93.6
ICD-10 Finland
Cerebral oedema
+∞
15.7
15
*
WW409
NOMESCO Finland
Other aferesis
+∞
15.7
15
*
C71.50
ICD-10 Finland
Malignant tumor of cerebral ventricle without histology
+∞
15.7
15
*
9382/3-C71.1
ICD-O-3
Oligoastrocytoma, NOS, of frontal lobe
+∞
15.7
15
*
G40
ICD-10 Finland
Epilepsy
10.2
15.5
30
30
PA4AC
NOMESCO Finland
Vertebralis angiography with X-ray
38.6
15.4
19
5
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
12.5
15.4
27
22
SPAT1153
SPAT
Removal of sutures
1.8
14.9
318
2022
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
32.1
14.8
19
6
WX892
NOMESCO Finland
Monitored bed care
2.8
14.8
100
383
C71.09
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles other or unspecified histology
+∞
14.6
14
*
9440/3-C71.8
ICD-O-3
Glioblastoma, NOS, of overlapping lesion of brain
+∞
14.6
14
*
XA400
NOMESCO Finland
EEG
14.4
14.6
24
17
PA3AC
NOMESCO Finland
Carotis angiography with X-ray
19.4
14.3
21
11
G40.89
ICD-10 Finland
Other epilepsy
14.6
14.1
23
16
C71.69
ICD-10 Finland
Malignant tumor of the cerebellum other or unspecified histology
+∞
13.6
13
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
13.6
13
*
ZXM20
NOMESCO Finland
Intraoperative use of computerised tomography
11.6
13.3
24
21
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.3
13.3
40
78
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
9.2
13.3
27
30
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
5.6
13.2
38
70
N02BE01
ATC
paracetamol; systemic, rectal
1.7
12.9
887
7682
2151
FHL
Resection, big brain
70.6
12.6
14
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.2
12.6
65
209
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
12.5
12
*
116
Kela drug reimbursment
Prostate cancer
+∞
12.5
12
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
12.5
12
*
9470/3-C71.6
ICD-O-3
Medulloblastoma, NOS, of cerebellum, NOS
+∞
12.5
12
*
C71.6
ICD-10 Finland
Malignant neoplasm: Cerebellum
+∞
12.5
12
*
C71.51
ICD-10 Finland
Malignant tumor of cerebral ventricle ependymoma
+∞
12.5
12
*
C71.59
ICD-10 Finland
Malignant tumor of cerebral ventricle other or unspecified histology
+∞
12.5
12
*
9440/3-C71.4
ICD-O-3
Glioblastoma, NOS, of occipital lobe
+∞
12.5
12
*
XX1AD
NOMESCO Finland
Other CT-examination
+∞
12.5
12
*
SPAT1245
SPAT
Provision of support and information to patient’s family members
3.6
12.4
55
157
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.0
12.3
171
928
A06AD11
ATC
lactulose; oral
2.1
12.2
145
737
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
6.9
12.0
29
43
PA7RT
NOMESCO Finland
Medical infusion to cerebral artery
47.1
11.9
14
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.3
11.9
114
528
N18
ICPC
Paralysis/weakness
5.7
11.8
33
59
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
5.1
11.7
36
72
WX730
NOMESCO Finland
Conventional respirator
5.4
11.7
34
64
N28
ICPC
Limited function/disability (N)
5.6
11.7
33
60
XW000
NOMESCO Finland
Bone marrow biopsy
4.2
11.7
44
109
G41.2
ICD-10 Finland
Complex partial status epilepticus
30.3
11.7
15
5
ZXA00
NOMESCO Finland
Right side
1.7
11.5
269
1739
AA5JS
NOMESCO Finland
Extensive PET-MRI of brain metabolism
+∞
11.5
11
*
C71.74
ICD-10 Finland
Malignant tumor of the brainstem ependyoma
+∞
11.5
11
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
11.5
11
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
11.5
11
*
23810
ICD-8 Finland
Neoplasm of unspecified nature of eye, brain and other parts of nervous system, Brain
121.1
11.4
12
*
D33.08
ICD-10 Finland
Another benign tumor of the cerebral ventricle
121.1
11.4
12
*
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.1
11.4
62
207
R41.0
ICD-10 Finland
Disorientation, unspecified
3.8
11.3
47
127
R50.9
ICD-10 Finland
Fever, unspecified
2.0
11.3
143
746
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
11.9
11.3
20
17
R51.80
ICD-10 Finland
Headache
2.0
11.3
162
889
C01DA14
ATC
isosorbide mononitrate; oral
0.4
11.2
40
1016
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.1
11.2
126
627
HAB40
NOMESCO Finland
Wedge excision of mammary gland
17.2
11.2
17
10
ZX120
NOMESCO Finland
Intravenous
2.5
11.0
84
346
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.5
11.0
77
1522
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.9
10.9
43
112
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.9
10.8
66
237
TPX15
NOMESCO Finland
Removal of vascular injection port
28.3
10.7
14
5
HA1AA
NOMESCO Finland
X-ray mammography
4.6
10.7
36
80
AA5DR
NOMESCO Finland
Brain metabolism PET with CT
21.7
10.7
15
7
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
60.5
10.6
12
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
5.4
10.6
31
59
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.3
10.6
26
777
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
0.5
10.6
82
1567
L28
ICPC
Limited function/disability (L)
1.9
10.5
156
867
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
110.9
10.4
11
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
110.9
10.4
11
*
9450/3-C71.3
ICD-O-3
Oligodendroglioma, NOS, of parietal lobe
+∞
10.4
10
*
9591/3-C71.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of brain, NOS
+∞
10.4
10
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
10.4
10
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
10.4
10
*
C71.7
ICD-10 Finland
Malignant neoplasm: Brain stem
+∞
10.4
10
*
9450/3-C71.2
ICD-O-3
Oligodendroglioma, NOS, of temporal lobe
+∞
10.4
10
*
9382/3-C71.9
ICD-O-3
Oligoastrocytoma, NOS, of brain, NOS
+∞
10.4
10
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
10.4
10
*
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.5
10.3
83
1570
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
13.2
10.2
17
13
N03AX11
ATC
topiramate; oral
4.0
10.1
39
100
101
Kela drug reimbursment
Anterior pituitary hypofunction
8.5
10.1
21
25
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
14.7
10.0
16
11
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.5
9.9
77
322
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
26.2
9.8
13
5
SAA01
NOMESCO Finland
Simple examination of mouth
0.7
9.7
502
6143
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.3
9.7
48
151
CS494
NOMESCO Finland
Other visual field testing
4.1
9.7
36
89
G83.9
ICD-10 Finland
Paralytic syndrome, unspecified
55.4
9.7
11
*
U07.2
ICD-10 Finland
COVID-19, virus not identified
0.4
9.6
48
1068
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
4.9
9.5
30
63
C71.42
ICD-10 Finland
Malignant tumor of the occipital lobe grade III glioma
+∞
9.4
9
*
C71.61
ICD-10 Finland
Malignant tumor of cerebellum grade II glioma
+∞
9.4
9
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
9.4
9
*
C71.92
ICD-10 Finland
Malignant tumor in an unspecified localization in the brain grade III glioma
+∞
9.4
9
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
9.4
9
*
AA003
NOMESCO Finland
Adjuvant radiotherapy of brain
+∞
9.4
9
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
9.4
9
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
9.4
9
*
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
7.4
9.2
21
29
ZXH01
NOMESCO Finland
Procedure performed within operation theatre
13.8
9.2
15
11
SPAT1229
SPAT
Assessment of need for aid
2.3
9.1
80
355
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.5
8.9
88
1571
G41.0
ICD-10 Finland
Grand mal status epilepticus
24.2
8.9
12
5
R93.0
ICD-10 Finland
Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified
24.2
8.9
12
5
L02BA01
ATC
tamoxifen; oral
24.2
8.9
12
5
S18
ICPC
Laceration/cut
1.5
8.9
385
2878
G81.9
ICD-10 Finland
Hemiplegia, unspecified
6.4
8.8
22
35
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
3.7
8.8
37
103
C10AX09
ATC
ezetimibe; oral
0.3
8.7
22
650
G40.39
ICD-10 Finland
Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures
14.1
8.7
14
10
22500
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Brain
50.3
8.7
10
*
AWC00
NOMESCO Finland
Reoperation of nervous system because of deep wound infection in the nervous system
50.3
8.7
10
*
TKC20
NOMESCO Finland
Catheterisation of bladder
2.4
8.6
74
324
ZXA05
NOMESCO Finland
Left side
1.6
8.6
241
1622
M25.5
ICD-10 Finland
Pain in joint
0.6
8.6
120
1950
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
4.1
8.6
32
80
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.3
8.6
75
334
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
27.7
8.5
11
*
A07AA02
ATC
nystatin; oral
2.5
8.4
64
263
YNB10
NOMESCO Finland
Collection of stem cells for transplant
90.6
8.4
9
*
R03AC02
ATC
salbutamol; inhalant
0.7
8.4
321
4193
WX002
NOMESCO Finland
Sedation and analgesia
1.7
8.3
186
1178
9400/3-C71.0
ICD-O-3
Astrocytoma, NOS, of cerebrum
+∞
8.3
8
*
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
+∞
8.3
8
*
9391/3-C71.7
ICD-O-3
Ependymoma, NOS, of brain stem
+∞
8.3
8
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
8.3
8
*
AA5FK
NOMESCO Finland
Functional assessment (fMRI) of brain
+∞
8.3
8
*
C71.49
ICD-10 Finland
Malignant tumor in occipital lobe other or unspecified histology
+∞
8.3
8
*
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
+∞
8.3
8
*
L01BC06
ATC
capecitabine; oral
+∞
8.3
8
*
9445/3-C71.9
ICD-O-3
Glioblastoma, IDH-mutant of brain, NOS
+∞
8.3
8
*
1911X
ICD-9 Finland
Malignant neoplasm of brain, Frontal lobe[AIVOJEN OTSALOHKON SYÖPÄ,EI HISTOLOGISTA VAHVISTUST]
+∞
8.3
8
*
C71.79
ICD-10 Finland
Malignant tumor of the brainstem other or unspecified histology
+∞
8.3
8
*
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
6.3
8.3
21
34
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.4
8.3
33
802
F80.1
ICD-10 Finland
Expressive language disorder
7.1
8.3
19
27
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
5.2
8.2
24
47
HAC20
NOMESCO Finland
Total mastectomy
33.6
8.1
10
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
33.6
8.1
10
*
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
6.1
7.9
20
33
H53.2
ICD-10 Finland
Diplopia
3.2
7.7
39
126
N03AF04
ATC
eslicarbazepine; oral
45.3
7.7
9
*
D33.05
ICD-10 Finland
Other lateral benign tumor in temporal lobe
45.3
7.7
9
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.0
7.7
92
471
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.6
7.7
21
38
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
0.5
7.6
71
1291
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
11.9
7.6
13
11
H47.1
ICD-10 Finland
Papilloedema, unspecified
11.9
7.6
13
11
SPAT1109
SPAT
Analgesia with portable analgesic pump
25.2
7.6
10
*
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.1
7.6
86
429
R11
ICD-10 Finland
Nausea and vomiting
2.2
7.5
75
356
M54.4
ICD-10 Finland
Lumbago with sciatica
0.5
7.5
51
1023
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
0.5
7.5
58
1115
I50.0
ICD-10 Finland
Congestive heart failure
0.3
7.4
11
423
ZX131
NOMESCO Finland
Intrathecal
80.5
7.4
8
*
1XC02
NOMESCO Finland
NA
13.4
7.4
12
9
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
0.5
7.3
77
1350
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
10.9
7.3
13
12
ZX000
NOMESCO Finland
Simple adjustment of radiotherapy with simulator or with therapeutic device - isocentric therapy
+∞
7.3
7
*
19107
ICD-8 Finland
Malignant neoplasm of brain, Cerebelli
+∞
7.3
7
*
8000/3-C71.1
ICD-O-3
Neoplasm, malignant of frontal lobe
+∞
7.3
7
*
C71.73
ICD-10 Finland
Malignant tumor of the brain stem grade IV glioma
+∞
7.3
7
*
AAF30
NOMESCO Finland
Implantation of intraventricular injection device
+∞
7.3
7
*
C72.9
ICD-10 Finland
Malignant neoplasm: Central nervous system, unspecified
+∞
7.3
7
*
8000/3-C71.2
ICD-O-3
Neoplasm, malignant of temporal lobe
+∞
7.3
7
*
C71.63
ICD-10 Finland
Malignant tumor of cerebellum grade IV glioma
+∞
7.3
7
*
D43
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of brain and central nervous system
+∞
7.3
7
*
9400/3-C71.3
ICD-O-3
Astrocytoma, NOS, of parietal lobe
+∞
7.3
7
*
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
7.3
7
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
7.3
7
*
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
5.2
7.3
21
41
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
0.7
7.2
240
3239
AWE00
NOMESCO Finland
Reoperation for deep heamorrhage in surgery of the nervous system
30.2
7.2
9
*
102
Kela drug reimbursment
Diabetes insipidus
20.1
7.1
10
5
RS221
NOMESCO Finland
NA
3.9
7.1
27
70
K91
ICPC
Cerebrovascular disease
5.7
7.1
19
34
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
8.8
7.1
14
16
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.1
7.0
74
360
I48
ICD-10 Finland
Atrial fibrillation and flutter
0.6
7.0
89
1482
C07AB07
ATC
bisoprolol; oral
0.7
7.0
269
3541
R03DC03
ATC
montelukast; oral
0.5
6.9
51
997
N88
ICPC
Epilepsy
7.6
6.9
15
20
XCK00
NOMESCO Finland
Perimetry
2.2
6.9
70
335
I50.9
ICD-10 Finland
Heart failure, unspecified
0.5
6.8
40
841
AA5NK
NOMESCO Finland
Tractography within white matter of central nervous system
40.3
6.8
8
*
2396A
ICD-9 Finland
Neoplasm of unspecified nature, Brain
40.3
6.8
8
*
N03AX15
ATC
zonisamide; oral
16.8
6.7
10
6
2152
FHL
Extraction, big brain
22.6
6.7
9
*
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
6.6
91
1492
R4190
NOMESCO Finland
Nutritional therapy
3.1
6.6
33
107
207
Kela drug reimbursment
Chronic arrhythmias
0.5
6.6
43
874
N19
ICPC
Speech disorder
4.1
6.6
24
60
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.7
6.6
138
854
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
0.3
6.6
19
529
N02AA01
ATC
morphine; systemic, rectal
8.7
6.6
13
15
H47.2
ICD-10 Finland
Optic atrophy
10.1
6.5
12
12
N80
ICPC
Head injury other
3.7
6.5
26
71
R83
ICPC
Respiratory infection other
0.6
6.4
104
1640
DFF20
NOMESCO Finland
Audiometry for children
70.2
6.4
7
*
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
0.7
6.4
194
2677
G91.0
ICD-10 Finland
Communicating hydrocephalus
7.4
6.4
14
19
SPAT1325
SPAT
Vaccination
0.7
6.4
172
2426
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
3.7
6.4
26
72
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
3.9
6.4
24
62
GD1AA
SPAT
NA
0.2
6.4
9
357
C10AA07
ATC
rosuvastatin; oral
0.6
6.3
102
1608
PA7BD
NOMESCO Finland
CT angiography of neck and brain
4.2
6.3
22
53
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
6.0
6.3
16
27
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
6.3
6
*
3AA13
NOMESCO Finland
NA
+∞
6.3
6
*
1CD02
NOMESCO Finland
NA
+∞
6.3
6
*
19100
ICD-8 Finland
Malignant neoplasm of brain, Lobi frontalis
+∞
6.3
6
*
L02BB03
ATC
bicalutamide; oral
+∞
6.3
6
*
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
+∞
6.3
6
*
A04AD12
ATC
aprepitant; systemic
+∞
6.3
6
*
9380/3-C71.2
ICD-O-3
Glioma, malignant of temporal lobe
+∞
6.3
6
*
1BC01
NOMESCO Finland
NA
+∞
6.3
6
*
C71.66
ICD-10 Finland
Malignant tumor of the cerebellum medullobastoma
+∞
6.3
6
*
9391/3-C71.5
ICD-O-3
Ependymoma, NOS, of ventricle, NOS
+∞
6.3
6
*
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
6.3
6
*
C72.3
ICD-10 Finland
Malignant neoplasm: Optic nerve
+∞
6.3
6
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
6.3
6
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
+∞
6.3
6
*
9382/3-C71.2
ICD-O-3
Oligoastrocytoma, NOS, of temporal lobe
+∞
6.3
6
*
C71.41
ICD-10 Finland
Malignant tumor of occipital lobe grade II glioma
+∞
6.3
6
*
9380/3-C71.1
ICD-O-3
Glioma, malignant of frontal lobe
+∞
6.3
6
*
AAK00
NOMESCO Finland
Cranioplasty
+∞
6.3
6
*
1911A
ICD-9 Finland
Malignant neoplasm of brain, Frontal lobe[AIVOJEN OTSALOHKON SYÖPÄ,ASTROCYTOMA (GR I-II)]
+∞
6.3
6
*
9401/3-C71.3
ICD-O-3
Astrocytoma, anaplastic, NOS, of parietal lobe
+∞
6.3
6
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
6.3
6
*
2159
FHL
Other measure in this category
26.8
6.2
8
*
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.4
6.2
31
688
ZX112
NOMESCO Finland
Subcutaneous
5.8
6.1
16
28
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
2.7
6.1
38
143
G40.1
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
8.6
6.1
12
14
JFB60
NOMESCO Finland
Resection of sigmoid colon with end colostomy
10.1
6.0
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
386
91
52.47
307.65
1.7
2.1
—
—
—
0
0
675
1565
6.03
291.59
7.3
7.2
1.1
1.2
mmol/l
0.21
510
1215
674
1574
5.98
288.56
7.3
7.2
5.0
5.1
kpa
3.99
644
1509
674
1574
5.98
288.56
7.3
7.2
17.6
11.7
kpa
74.72
644
1506
125
19
70.16
229.59
1.1
1.3
—
—
—
0
0
724
2151
4.73
226.52
2.2
2.3
27.3
29.9
s
23.13
704
2085
96
16
63.01
173.20
1.4
1.3
—
—
—
0
0
158
0
+∞
167.09
1.1
0.0
—
—
—
0
0
126
75
17.88
153.22
2.4
2.3
54.5
54.8
umol/l
0.02
110
61
159
144
11.92
152.33
2.0
1.6
—
—
—
0
0
234
351
7.43
151.59
2.0
1.4
2671.6
1356.4
e6/l
0.62
188
295
233
351
7.39
150.33
1.9
1.4
56.0
35.7
e6/l
0.33
183
285
1257
6861
3.28
140.34
13.3
4.0
9.9
12.3
umol/l
16.22
1229
6422
813
3465
3.29
138.69
4.2
3.7
95.1
88.5
%
13.65
792
3370
1158
6155
3.13
132.89
8.7
5.5
1.2
1.2
mmol/l
13.09
1122
5499
742
3076
3.26
131.34
2.5
2.1
—
—
—
0
0
212
355
6.57
123.21
1.7
1.2
3.6
3.9
mmol/l
1.42
206
332
1209
6805
3.00
121.07
9.2
5.8
1.2
1.2
mmol/l
7.73
1080
5762
420
1279
3.90
119.31
8.9
8.0
127.6
123.7
g/l
3.48
405
1234
431
1400
3.66
110.70
9.3
7.6
97.8
95.2
%
17.98
414
1354
913
4628
2.81
107.77
2.7
2.1
174.9
245.6
u/l
1.40
895
4348
1359
8528
2.90
104.41
8.7
4.4
6.7
6.8
mmol/l
0.09
1328
7923
99
83
12.50
99.21
1.8
1.8
—
—
—
0
0
1285
8023
2.72
96.23
18.9
6.7
4.1
4.3
e9/l
0.86
1133
6937
83
62
13.93
89.06
2.1
2.1
—
—
—
0
0
1058
6223
2.51
86.29
4.5
3.6
—
—
—
0
0
499
2030
2.95
86.21
4.5
3.0
0.8
0.8
mmol/l
1.29
475
1879
84
75
11.65
80.74
2.0
2.1
10.9
12.2
%
0.31
40
42
98
111
9.24
79.60
1.8
1.2
2.5
2.0
mmol/l
1.89
92
105
1090
6732
2.38
76.49
10.5
5.7
2.0
2.9
%
43.48
1058
6232
801
4339
2.42
75.70
8.3
2.0
2.4
2.4
mmol/l
0.06
746
3679
355
1305
3.10
72.39
2.7
1.9
334.9
357.7
nmol/l
0.51
336
1188
1101
6954
2.32
71.60
10.8
5.8
23.9
28.3
%
31.66
1070
6449
1083
6880
2.27
68.28
10.6
5.6
61.1
57.0
%
20.77
1053
6403
70
62
11.67
67.55
3.1
2.7
28.5
30.4
umol/l
0.54
55
42
945
5748
2.23
65.38
6.1
4.0
34.8
36.0
g/l
8.02
900
5293
1236
15520
0.46
57.50
3.9
4.8
2.8
2.7
mmol/l
2.96
1123
14386
221
697
3.44
57.43
12.2
10.7
—
—
—
0
0
1206
15241
0.46
55.93
3.6
4.4
4.7
4.6
mmol/l
1.94
1099
14209
40
17
23.99
55.73
1.9
1.9
—
—
—
0
0
68
80
8.77
53.50
1.3
1.1
—
—
—
0
0
302
1192
2.81
53.13
6.3
6.7
1.4
1.4
mmol/l
0.34
288
1143
1202
15137
0.47
53.03
3.6
4.3
1.4
1.4
mmol/l
0.03
1102
14033
302
1209
2.77
51.63
4.9
7.3
6.7
9.7
mmol/l
13.13
285
1147
1167
14631
0.51
45.14
3.4
3.9
1.3
1.3
mmol/l
0.67
1074
13469
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
62
85
7.50
42.94
1.3
1.1
—
—
—
0
0
111
266
4.36
42.45
3.2
5.3
352.0
365.4
umol/l
0.41
103
234
61
84
7.46
42.08
2.0
2.4
465.1
469.6
e6/l
0.02
49
74
55
70
8.05
40.57
2.0
1.1
64.7
53.8
%
—
21
8
59
82
7.39
40.37
2.1
2.4
0.2
0.2
e9/l
1.82
49
73
229
898
2.75
40.29
13.5
7.2
25.2
24.6
mmol/l
2.02
211
846
442
2368
2.12
38.38
4.1
2.1
2.4
2.4
mmol/l
0.08
405
2010
1396
10954
1.93
37.85
14.9
5.4
74.6
76.4
u/l
0.83
1366
10184
1131
14090
0.54
37.81
4.7
5.7
39.2
39.9
mmol/mol
1.83
1051
13125
112
300
3.90
36.85
16.7
7.6
105.6
105.4
mmol/l
0.13
97
272
416
2232
2.09
35.71
2.1
1.7
—
—
—
0
0
149
500
3.14
34.62
1.9
2.3
280.1
460.8
ug/l
0.68
141
466
75
161
4.80
32.85
1.1
1.0
—
—
—
0
0
317
1581
2.20
32.61
2.0
1.7
—
—
—
0
0
75
163
4.74
32.37
5.6
7.2
9.6
11.4
mg/l
2.79
69
150
1236
14818
0.56
32.26
4.1
4.4
5.9
6.0
mmol/l
0.94
1123
13547
317
1589
2.18
32.17
2.0
1.7
—
—
—
0
0
596
3793
1.82
30.12
3.1
2.9
0.5
0.4
e6/l
0.47
462
2832
91
244
3.86
29.88
4.3
5.9
251.8
460.0
iu/ml
0.50
16
33
52
94
5.65
27.62
1.1
1.1
1.4
1.1
u/l
1.30
31
46
162
645
2.65
27.41
2.8
1.6
37.3
3.6
ug/l
0.57
122
479
45
71
6.46
27.40
2.6
2.4
40.0
45.1
%
0.81
24
24
34
40
8.63
26.67
5.3
2.5
—
—
—
0
0
191
835
2.43
26.54
1.5
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
117
398
3.06
26.51
3.5
4.2
0.4
0.4
u/ml
0.68
75
234
145
558
2.73
26.22
14.0
5.1
1.6
1.6
%
0.51
130
526
66
155
4.37
25.90
3.4
2.8
2.2
1.3
%
0.74
56
115
143
550
2.72
25.88
14.2
5.2
1.0
0.9
%
4.86
128
519
20
11
18.36
24.74
1.4
1.5
—
—
—
0
0
37
53
7.10
24.63
1.4
1.1
—
—
—
0
0
255
1300
2.10
24.41
4.8
3.1
256.1
234.6
u/l
1.94
245
1223
211
4029
0.47
24.41
1.6
1.6
1.3
1.4
mmol/l
0.50
180
3406
21
14
15.15
23.66
1.4
4.1
—
—
—
0
0
54
116
4.76
23.66
1.1
1.2
97.7
37.2
mg/l
1.17
44
97
39
62
6.40
23.57
1.2
1.1
1096.8
120.9
ng/l
0.74
13
15
39
63
6.29
23.21
1.1
1.2
—
—
—
0
0
52
112
4.74
22.72
1.1
1.1
623.3
261.3
mg/l
1.08
44
100
51
113
4.61
21.54
1.0
1.1
—
—
—
0
0
51
113
4.61
21.54
3.1
2.2
—
—
—
0
0
354
2141
1.80
20.17
2.6
2.7
2.5
2.5
e6/l
0.01
191
1128
54
134
4.11
19.76
1.7
1.3
—
—
—
0
0
105
397
2.74
19.63
2.8
3.0
3.1
3.5
g/l
2.03
105
374
371
2305
1.75
19.19
2.6
2.6
1.1
1.3
e6/l
0.29
208
1292
55
143
3.93
18.90
1.6
1.5
284.0
279.3
mosm/kgh2o
0.74
46
104
305
1796
1.83
18.89
5.2
5.7
1.0
1.0
mmol/l
0.90
290
1657
86
299
2.96
18.78
1.6
3.0
28.3
37.7
umol/l
1.97
69
258
82
279
3.02
18.60
2.2
1.5
—
—
—
0
0
97
377
2.65
17.20
1.8
1.7
—
—
—
0
0
165
812
2.13
17.17
1.6
1.6
—
—
—
0
0
1586
17236
0.60
17.15
38.1
17.5
7.0
6.7
e9/l
4.07
1543
16692
1586
17235
0.60
17.12
38.6
17.5
133.4
137.6
g/l
24.62
1572
16948
42
96
4.45
17.10
2.4
2.2
570.6
876.0
e6/l
1.71
14
39
81
288
2.89
17.01
2.1
1.5
—
—
—
0
0
1586
17229
0.60
16.95
38.2
17.4
4.4
4.6
e12/l
30.01
1541
16678
75
258
2.98
16.71
2.6
2.2
35.1
58.4
u/ml
0.29
65
209
32
59
5.50
16.68
1.2
1.1
—
—
—
0
0
1586
17214
0.60
16.53
38.2
17.4
238.1
248.4
e9/l
7.10
1544
16721
73
251
2.98
16.28
1.6
1.7
—
—
—
0
0
1132
9389
1.48
15.85
4.4
4.1
3039.7
2035.4
e6/l
0.17
18
134
63
202
3.19
15.83
2.3
1.5
—
—
—
0
0
22
30
7.40
15.26
1.3
1.5
—
—
—
0
0
75
273
2.82
15.11
2.1
2.3
17.0
16.8
%
0.08
33
143
19
22
8.71
15.02
2.0
1.1
57.5
53.6
%
—
11
8
311
4680
0.60
14.83
3.5
4.0
10.5
8.3
mg/mmol
0.29
178
3022
186
1014
1.92
14.53
3.0
2.4
8.7
10.7
g/l
11.52
174
935
110
499
2.28
14.00
2.0
1.7
1.0
1.4
ug/l
0.24
91
434
329
4822
0.62
13.86
2.9
3.3
8.3
7.9
mmol/l
0.67
268
4104
125
2402
0.49
13.77
1.2
1.2
7.6
10.8
u/ml
0.29
44
943
55
177
3.17
13.77
2.2
1.5
—
—
—
0
0
230
1363
1.78
13.75
5.6
3.7
5.7
5.9
kpa
1.90
221
1318
41
113
3.68
13.04
1.9
1.4
—
—
—
0
0
245
1501
1.72
13.02
2.7
2.7
6.5
8.0
umol/l
0.88
210
1290
141
727
2.01
12.94
6.3
4.2
24.9
24.2
mmol/l
2.36
130
651
18
8
22.69
12.89
1.6
2.8
—
—
—
0
0
225
1354
1.75
12.73
5.7
3.7
2.1
2.0
mmol/l
0.33
191
1077
161
880
1.90
12.47
1.9
1.5
—
—
—
0
0
92
410
2.30
12.23
2.4
1.5
6.2
7.5
u/l
0.73
73
335
412
2910
1.53
12.16
2.7
2.4
5.6
5.6
e6/l
0.01
377
2529
818
9857
0.71
12.12
2.9
3.0
—
—
—
0
0
83
365
2.33
11.40
1.4
1.2
—
—
—
0
0
104
504
2.12
11.29
2.2
1.4
20.1
23.2
iu/l
0.49
88
424
408
2926
1.50
11.09
3.1
3.7
124.0
608.1
ng/l
6.14
311
2263
146
2502
0.55
10.97
1.2
1.3
28.6
34.8
iu/ml
0.29
43
781
37
108
3.47
10.86
1.2
1.1
—
—
—
0
0
190
1140
1.74
10.84
5.7
3.3
4.8
4.6
kpa
0.46
183
1097
602
4666
1.42
10.83
5.1
2.8
31.2
36.5
u/l
0.82
580
4432
18
29
6.25
10.74
1.1
1.1
—
—
—
0
0
12
12
10.05
10.44
1.2
1.3
—
—
—
0
0
705
5642
1.39
10.43
3.8
3.6
32.9
60.7
ng/l
1.64
532
3809
1250
13919
0.72
10.38
4.5
4.5
1.7
2.1
mu/l
2.43
1155
12771
23
49
4.74
10.24
1.2
1.1
—
—
—
0
0
14
18
7.83
10.15
1.1
1.3
—
—
—
0
0
42
139
3.07
10.10
2.3
1.7
—
—
—
0
0
54
207
2.65
9.95
1.7
1.4
—
—
—
0
0
9
0
+∞
9.38
1.1
0.0
—
—
—
0
0
30
85
3.57
9.23
1.7
1.6
—
—
—
0
0
19
38
5.04
9.10
1.1
1.1
—
—
—
0
0
39
135
2.93
8.72
1.3
1.1
—
—
—
0
0
42
152
2.80
8.67
1.7
1.4
—
—
—
0
0
10
10
10.05
8.65
1.2
1.2
—
—
—
0
0
21
48
4.41
8.62
1.2
1.1
—
—
—
0
0
21
48
4.41
8.62
1.2
1.1
—
—
—
0
0
68
319
2.17
8.09
1.4
1.4
—
—
—
0
0
68
319
2.17
8.09
1.4
1.4
—
—
—
0
0
210
1400
1.56
7.89
4.6
2.9
—
—
—
0
0
52
223
2.37
7.65
1.4
1.5
—
—
—
0
0
12
18
6.70
7.61
1.1
1.1
—
—
—
0
0
162
1027
1.63
7.52
2.1
2.4
12.7
22.3
au/ml
—
5
56
22
59
3.76
7.36
1.0
1.0
—
—
—
0
0
44
178
2.51
7.35
1.7
1.4
—
—
—
0
0
31
105
2.98
7.24
2.2
2.9
70.2
55.1
%
3.61
25
67
20
51
3.95
7.16
1.3
1.1
—
—
—
0
0
40
163
2.48
6.61
2.0
1.5
0.2
0.3
nmol/l
1.72
34
140
156
1014
1.58
6.55
6.1
2.8
1.2
1.2
mmol/l
1.48
146
855
89
498
1.82
6.50
1.8
1.6
—
—
—
0
0
15
33
4.57
6.46
1.4
1.4
—
—
—
0
0
74
391
1.93
6.45
2.4
3.1
—
—
—
0
0
33
124
2.69
6.42
1.3
1.4
0.9
1.3
promille
0.60
25
92
27
93
2.93
6.16
2.5
1.5
—
—
—
0
0
12
23
5.24
6.01
1.4
1.0
—
—
—
0
0
48
226
2.15
5.75
1.1
1.1
—
—
—
0
0
988
10986
0.80
5.68
3.7
4.0
11.5
11.0
mm/h
0.52
926
10179
17
46
3.72
5.64
1.2
1.1
—
—
—
0
0
1041
11499
0.80
5.59
4.2
3.7
14.6
14.8
pmol/l
0.68
965
10491
88
521
1.72
5.36
2.5
1.7
399.1
293.3
mu/l
1.16
83
473
21
68
3.11
5.34
2.1
1.4
—
—
—
0
0
5
0
+∞
5.21
1.0
0.0
—
—
—
0
0
36
158
2.30
5.13
1.9
1.4
—
—
—
0
0
534
6305
0.79
5.03
2.4
2.8
195.4
120.0
ug/l
2.55
489
5817
9
9
10.04
5.02
8.4
1.0
18.1
16.4
u/ml
—
9
9
443
5342
0.78
4.96
3.5
3.6
2.8
1.9
ug/l
1.16
392
4801
210
1541
1.41
4.89
3.0
2.5
1.8
1.7
%
0.71
188
1359
1553
16314
0.78
4.89
18.5
8.6
31.9
27.0
u/l
14.08
1527
15696
105
669
1.60
4.86
3.4
2.7
1.2
1.3
%
0.75
105
664
121
1786
0.66
4.82
2.5
2.5
230.5
139.1
ug/g
0.75
104
1428
155
1080
1.47
4.77
1.8
2.2
0.2
0.2
g/l
4.80
147
983
1323
14129
0.81
4.62
29.1
13.1
39.0
40.4
%
6.36
968
10275
120
801
1.53
4.55
2.8
3.0
4.2
4.6
pmol/l
3.16
112
698
10
21
4.78
4.53
1.2
1.2
—
—
—
0
0
347
4272
0.77
4.53
3.0
3.5
23.1
23.9
%
0.43
152
1866
18
59
3.07
4.52
2.3
1.5
—
—
—
0
0
18
59
3.07
4.52
2.2
1.5
—
—
—
0
0
13
35
3.73
4.36
1.2
2.5
21.3
18.6
umol/l
0.30
13
35
14
40
3.52
4.33
2.1
2.6
—
—
—
0
0
86
538
1.63
4.32
2.1
1.6
—
—
—
0
0
12
31
3.89
4.25
2.3
1.2
—
—
—
0
0
12
31
3.89
4.25
2.3
1.2
—
—
—
0
0
12
31
3.89
4.25
2.3
1.2
—
—
—
0
0
133
922
1.47
4.23
3.6
4.9
1.9
1.7
mmol/l
0.31
106
669
95
1433
0.65
4.21
1.6
1.7
—
—
—
0
0
27
580
0.46
4.13
1.2
1.5
—
—
—
0
0
17
57
3.00
4.12
4.4
3.2
1.2
1.6
ug/l
0.29
17
50
50
272
1.86
4.11
1.3
1.5
82.4
100.5
u/ml
—
9
49
63
368
1.74
4.10
2.2
4.6
24.8
25.0
mmol/l
0.14
57
329
258
3258
0.76
4.05
1.2
1.3
2.2
1.7
u/ml
0.20
70
879
30
612
0.48
3.99
1.2
1.7
2.7
4.6
mg/l
0.96
21
420
143
1971
0.70
3.97
1.6
1.8
1.8
1.5
%
2.26
121
1754
1561
16303
0.80
3.93
30.0
13.4
71.5
78.1
umol/l
15.50
1561
16297
343
4163
0.79
3.93
2.8
3.1
788.6
1424.3
ng/l
5.63
306
3535
10
24
4.18
3.89
1.8
1.5
—
—
—
0
0
16
412
0.38
3.85
1.2
1.3
—
—
—
0
0
519
5996
0.82
3.75
1.8
1.9
94.3
95.0
pmol/l
0.15
287
3126
211
2706
0.75
3.69
1.4
1.5
—
—
—
0
0
60
974
0.60
3.69
1.4
1.3
352.8
265.9
u/ml
0.28
55
902
39
205
1.92
3.59
1.6
2.0
—
1370.0
—
0
8
46
256
1.82
3.56
4.2
3.3
5.0
4.2
e9/l
0.88
46
256
9
17
5.31
3.51
1.9
1.3
—
—
—
0
0
8
13
6.17
3.50
1.8
4.8
—
—
—
0
0
13
41
3.19
3.49
1.2
1.0
95.7
87.6
%
—
6
22
23
100
2.32
3.43
2.3
1.2
—
—
—
0
0
23
100
2.32
3.43
2.3
1.2
—
—
—
0
0
23
100
2.32
3.43
2.3
1.2
—
—
—
0
0
165
1243
1.36
3.33
2.1
2.3
36.5
76.9
u/l
0.53
138
1051
320
3845
0.80
3.31
3.2
2.4
3452.5
5359.1
umol/l
0.46
288
3348
6
7
8.59
3.26
1.0
1.0
—
—
—
0
0
6
7
8.59
3.26
1.0
1.0
—
—
—
0
0
46
264
1.76
3.25
5.3
3.5
60.5
57.3
%
0.75
46
264
245
3017
0.79
3.13
2.3
2.5
0.7
0.7
ug/l
0.31
159
1879
6
8
7.52
3.05
1.2
1.1
—
—
—
0
0
128
1717
0.73
3.05
1.8
2.1
—
—
—
0
0
92
638
1.46
3.00
4.8
3.5
52.4
48.7
%
0.79
92
627
12
40
3.01
2.97
1.2
1.1
95.4
85.3
%
—
5
21
114
1550
0.72
2.96
1.7
2.0
—
—
—
0
0
522
5917
0.84
2.93
2.2
2.3
72.5
76.3
nmol/l
2.57
478
5285
13
47
2.78
2.81
2.3
1.2
—
—
—
0
0
13
47
2.78
2.81
2.3
1.2
—
—
—
0
0
13
47
2.78
2.81
2.3
1.2
—
—
—
0
0
13
47
2.78
2.81
2.3
1.2
—
—
—
0
0
5
6
8.35
2.75
1.0
1.3
—
—
—
0
0
33
181
1.84
2.74
1.2
1.2
—
—
—
0
0
8
19
4.22
2.68
1.1
1.7
—
—
—
0
0
7
202
0.34
2.65
1.3
1.5
—
—
—
0
0
152
1174
1.32
2.64
2.6
2.3
11.8
14.2
nmol/l
3.52
130
1040
138
1788
0.75
2.62
3.6
4.5
31.6
32.2
%
0.31
107
1220
7
15
4.68
2.59
1.1
1.1
—
—
—
0
0
49
307
1.61
2.57
1.9
2.1
131.7
133.5
g/l
0.17
40
230
13
302
0.43
2.55
1.2
1.1
7.6
1.6
u/ml
—
8
148
6
11
5.47
2.54
1.0
1.7
—
—
—
0
0
7
194
0.36
2.54
1.0
1.1
—
—
—
0
0
35
579
0.60
2.42
1.5
1.8
—
—
—
0
0
46
290
1.60
2.37
1.6
1.5
—
—
—
0
0
7
17
4.13
2.36
1.1
1.1
—
—
—
0
0
152
1914
0.78
2.35
1.4
1.4
—
—
—
0
0
312
3624
0.83
2.26
1.9
2.2
2.9
2.9
mg/l
0.13
262
3074
22
405
0.54
2.26
1.6
1.5
—
—
—
0
0
9
29
3.11
2.22
1.2
1.0
—
—
—
0
0
10
241
0.41
2.19
2.1
1.7
—
—
—
0
0
9
30
3.01
2.14
1.2
1.0
—
—
—
0
0
285
3312
0.84
2.07
1.5
1.5
18.9
20.3
nmol/l
0.90
251
2812
6
15
4.01
2.04
1.0
1.3
—
—
—
0
0
13
273
0.47
2.02
1.2
1.5
—
—
—
0
0
15
70
2.15
1.98
1.1
1.1
1180.4
1687.3
miu/ml
0.85
15
70
272
3155
0.84
1.94
1.6
1.7
49569451.7
41025093.6
pmol/l
0.06
232
2635
10
39
2.57
1.92
1.3
1.1
—
—
—
0
0
19
342
0.55
1.86
1.2
1.5
—
—
—
0
0
6
17
3.54
1.84
1.3
1.1
—
—
—
0
0
64
868
0.73
1.73
1.5
2.0
—
—
—
0
0
49
694
0.70
1.72
1.5
1.9
—
—
—
0
0
18
319
0.56
1.69
1.2
1.4
—
—
—
0
0
18
319
0.56
1.69
1.2
1.4
—
—
—
0
0
18
318
0.56
1.67
1.2
1.4
—
—
—
0
0
18
317
0.56
1.66
1.2
1.4
—
—
—
0
0
139
1135
1.24
1.64
3.8
2.2
72.8
68.3
ml/min/173m2
0.46
40
442
1054
10009
1.11
1.62
3.7
3.0
63.3
45.3
u/l
3.33
1002
9331
82
629
1.32
1.60
1.5
2.0
33.7
38.9
u/l
1.85
75
552
6
20
3.01
1.58
1.0
1.2
—
—
—
0
0
23
374
0.61
1.58
1.1
1.4
—
—
—
0
0
57
772
0.73
1.56
1.0
1.0
—
—
—
0
0
1368
14144
0.89
1.53
23.9
10.7
90.1
82.0
ml/min/173m2
36.84
1204
11395
291
3289
0.86
1.51
3.7
3.8
1.0
1.0
kg/l
0.41
56
468
6
21
2.86
1.50
1.8
1.1
—
—
—
0
0
43
300
1.44
1.49
5.1
2.5
1.5
1.6
mmol/l
0.80
43
287
222
1917
1.18
1.49
11.8
26.5
1.3
1.4
inr
0.73
40
268
45
320
1.42
1.42
1.3
1.4
—
—
—
0
0
39
270
1.45
1.42
1.4
1.3
—
—
—
0
0
44
610
0.71
1.41
1.0
1.1
—
1.7
—
0
9
5
122
0.41
1.37
45.8
19.8
906.6
1410.2
nmol/l
—
5
117
25
160
1.57
1.31
1.9
1.3
—
—
—
0
0
519
5604
0.90
1.29
3.9
3.5
—
—
—
0
0
9
44
2.05
1.27
1.3
1.3
—
—
—
0
0
9
44
2.05
1.27
1.3
1.3
—
—
—
0
0
5
119
0.42
1.24
17.6
15.3
542.6
794.9
nmol/l
—
5
113
33
464
0.71
1.19
1.5
1.9
—
—
—
0
0
11
57
1.94
1.17
1.3
1.2
—
—
—
0
0
29
199
1.46
1.14
1.4
1.3
0.6
0.7
nmol/l
0.03
29
189
23
150
1.54
1.14
1.6
1.3
—
—
—
0
0
38
277
1.38
1.10
5.6
2.6
7.1
7.4
mmol/l
0.39
38
265
5
21
2.38
1.09
1.0
1.0
—
—
—
0
0
22
144
1.53
1.08
1.6
1.3
—
—
—
0
0
22
145
1.52
1.06
1.6
1.3
—
—
—
0
0
20
301
0.66
1.05
1.1
1.2
—
5.2
—
0
21
6
124
0.48
1.05
1.0
1.5
—
—
—
0
0
22
146
1.51
1.03
1.6
1.3
—
—
—
0
0
11
60
1.84
1.03
1.9
1.8
179.5
194.5
u/l
0.44
11
60
30
214
1.41
0.99
1.0
1.1
—
—
—
0
0
11
61
1.81
0.98
1.1
1.3
4.9
4.7
umol/l
0.06
11
56
5
23
2.18
0.98
3.4
8.4
—
—
—
0
0
22
148
1.49
0.98
1.6
1.3
—
—
—
0
0
0
30
0.00
0.97
0.0
1.1
—
47.0
—
0
30
9
50
1.80
0.96
1.3
1.7
—
1903858.3
iu/ml
—
0
6
11
62
1.78
0.94
2.2
2.5
—
—
—
0
0
40
304
1.32
0.92
1.4
1.4
273.1
247.8
u/ml
0.14
27
183
19
126
1.51
0.91
1.1
1.1
—
—
—
0
0
6
29
2.07
0.89
1.0
1.4
—
—
—
0
0
9
155
0.58
0.88
1.6
1.6
—
—
—
0
0
38
290
1.32
0.86
1.5
1.6
—
—
—
0
0
14
216
0.65
0.86
1.1
1.1
—
—
—
0
0
29
389
0.74
0.84
2.9
2.3
113.6
111.4
ug/min
0.01
15
249
10
57
1.76
0.83
3.2
1.2
—
—
—
0
0
0
24
0.00
0.79
0.0
1.3
—
114.4
—
0
24
11
66
1.67
0.78
1.4
1.7
—
—
—
0
0
11
66
1.67
0.78
1.4
1.7
—
—
—
0
0
153
1361
1.13
0.77
2.1
2.4
4.6
8.0
ug/l
3.91
135
1201
29
217
1.34
0.77
1.1
1.2
5.0
5.7
u/ml
0.11
11
101
19
132
1.44
0.76
1.1
1.1
—
—
—
0
0
21
149
1.41
0.75
1.6
1.2
—
—
—
0
0
5
25
2.00
0.72
1.0
1.2
108.6
94.6
%
—
5
25
5
25
2.00
0.72
1.0
1.2
—
—
—
0
0
9
56
1.61
0.72
1.3
1.2
—
—
—
0
0
36
454
0.79
0.70
1.3
1.3
113.0
231.2
miu/ml
1.04
11
201
17
118
1.44
0.69
2.2
2.3
594.8
622.3
ml
0.20
11
80
64
758
0.84
0.69
1.2
1.3
—
—
—
0
0
7
118
0.59
0.68
1.0
1.1
—
49.3
—
0
6
7
120
0.58
0.67
1.0
1.1
—
68.2
—
0
12
5
28
1.79
0.66
1.0
1.2
—
—
—
0
0
31
242
1.29
0.64
1.3
1.1
—
—
—
0
0
51
423
1.21
0.64
2.4
2.1
2164.9
3344.8
u/l
0.23
17
184
82
943
0.86
0.63
1.2
1.2
204.8
143.2
iu/ml
0.34
22
376
55
463
1.19
0.60
1.1
1.4
—
—
—
0
0
1545
15223
1.07
0.59
26.5
12.0
20.6
22.9
mg/l
2.77
1439
11717
29
229
1.27
0.57
1.1
1.2
1.3
4.5
u/ml
—
8
80
14
190
0.73
0.49
1.1
1.3
—
—
—
0
0
34
410
0.83
0.48
1.5
1.5
—
—
—
0
0
423
4421
0.95
0.47
2.4
2.3
54.5
58.5
u/l
1.80
398
4065
66
579
1.14
0.47
1.9
1.7
1.8
1.5
g/l
1.44
57
500
7
48
1.46
0.46
1.0
1.1
—
—
—
0
0
40
469
0.85
0.43
1.7
1.7
0.0
0.2
iu/ml
—
8
92
1290
12694
1.05
0.43
33.4
14.4
13.9
13.6
%
9.95
1277
12384
15
113
1.33
0.42
1.2
1.4
—
—
—
0
0
8
58
1.38
0.41
1.4
1.1
131.6
77.3
u/l
—
8
43
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
8
59
1.36
0.41
1.4
1.1
38.6
19.6
u/l
—
8
41
5
34
1.47
0.40
1.0
1.1
280.2
239.2
pmol/l
—
5
24
8
113
0.71
0.37
1.0
1.2
—
—
—
0
0
8
113
0.71
0.37
1.0
1.2
—
—
—
0
0
8
116
0.69
0.37
1.0
1.1
—
—
—
0
0
8
116
0.69
0.37
1.0
1.1
—
—
—
0
0
8
116
0.69
0.37
1.0
1.1
—
—
—
0
0
47
412
1.14
0.36
1.2
1.1
—
—
—
0
0
9
71
1.27
0.36
1.4
1.9
—
—
—
0
0
17
211
0.80
0.34
1.1
1.1
3.4
2.3
u/ml
—
6
96
36
314
1.15
0.31
3.3
3.4
33.8
25.6
mg/l
0.32
19
200
94
1016
0.92
0.31
2.9
4.2
87.7
90.2
ng/l
0.08
82
896
15
186
0.80
0.31
1.1
1.1
1.5
1.5
g/l
0.04
15
165
10
75
1.34
0.30
1.0
1.0
—
—
—
0
0
19
157
1.21
0.29
1.1
1.1
102.0
95.8
%
0.49
19
150
8
106
0.75
0.29
1.5
1.2
—
—
—
0
0
8
106
0.75
0.29
1.5
1.2
—
—
—
0
0
7
57
1.23
0.29
1.4
2.0
0.8
8.3
nmol/l
—
7
46
705
7198
0.97
0.28
5.1
4.6
0.0
0.0
estimate
0.50
148
1280
44
393
1.12
0.28
2.6
1.4
0.1
0.0
g/l
0.37
38
362
10
129
0.77
0.28
1.1
1.1
—
—
—
0
0
11
85
1.30
0.28
1.3
1.6
—
—
—
0
0
42
375
1.12
0.27
3.4
1.5
43.7
49.6
mg/l
0.12
35
305
42
375
1.12
0.27
3.4
1.5
37.7
43.2
mg/l
0.35
34
306
75
692
1.09
0.27
2.6
2.6
0.4
0.2
e6/l
0.38
75
671
375
3868
0.96
0.27
3.9
3.7
0.0
0.0
estimate
1.08
137
1242
112
1052
1.07
0.26
3.6
1.6
65.2
67.2
g/l
1.47
100
953
10
77
1.30
0.26
1.2
1.5
6.0
7.3
u/l
—
5
38
9
74
1.22
0.25
1.0
1.5
—
—
—
0
0
41
370
1.11
0.23
2.7
1.4
0.0
0.0
g/l
0.00
35
340
12
147
0.82
0.23
2.5
4.0
—
—
—
0
0
265
2739
0.96
0.22
1.7
1.7
1066.7
1182.9
nmol/l
1.57
207
2086
32
357
0.89
0.21
1.4
2.0
5.0
4.7
iu/l
0.06
11
136
326
3168
1.03
0.21
1.9
1.8
2.0
1.2
mg/l
1.84
262
2378
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
7.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
9
111
0.81
0.20
1.2
1.5
0.8
1.0
g/l
—
9
111
184
1772
1.04
0.19
2.2
2.6
25.8
23.7
%
0.89
158
1524
40
365
1.10
0.19
2.7
1.4
0.0
0.0
g/l
0.00
35
339
51
551
0.92
0.19
1.6
1.8
38.8
38.5
nmol/l
0.04
51
530
7
59
1.19
0.18
1.0
1.1
—
—
—
0
0
708
7182
0.98
0.18
3.5
3.4
0.0
0.0
estimate
0.00
145
1257
14
119
1.18
0.17
4.1
2.4
1.9
1.9
u/field
—
7
57
22
247
0.89
0.17
1.3
1.1
—
11.9
—
0
16
7
88
0.79
0.14
1.0
1.1
—
—
—
0
0
52
489
1.07
0.14
2.3
1.4
10.6
10.6
g/l
0.03
41
419
10
84
1.19
0.14
1.2
1.2
—
—
—
0
0
1572
15654
1.02
0.13
29.4
14.1
138.9
139.7
mmol/l
21.58
1554
15222
719
7262
0.98
0.12
3.7
3.4
0.0
0.0
estimate
1.08
142
1229
44
415
1.06
0.11
2.6
1.4
38.1
37.9
g/l
0.09
37
358
123
1267
0.97
0.11
1.9
3.2
98.0
219.9
ng/l
9.38
109
1164
45
475
0.95
0.11
1.8
1.8
—
—
—
0
0
30
280
1.07
0.10
1.5
1.6
—
—
—
0
0
42
443
0.95
0.10
1.2
1.1
—
—
—
0
0
51
488
1.05
0.09
2.4
1.4
2.9
3.1
g/l
0.56
40
390
216
2127
1.02
0.07
2.1
2.5
14.3
13.7
umol/l
0.48
199
1958
9
86
1.05
0.07
1.2
1.0
—
—
—
0
0
13
119
1.09
0.06
1.2
1.2
60.5
81.7
u/l
—
8
86
40
412
0.97
0.04
1.4
1.3
—
—
—
0
0
11
119
0.92
0.04
1.2
1.0
290.9
279.8
mg/l
0.20
11
109
26
251
1.04
0.02
1.0
1.1
1.0
126.4
iu/ml
—
6
62
43
440
0.98
0.02
1.2
1.1
—
—
—
0
0
45
440
1.02
0.02
2.6
1.4
1.3
0.4
g/l
0.92
37
386
195
1936
1.01
0.02
2.1
2.5
2.3
2.3
g/l
0.64
183
1797
1572
15710
1.00
0.01
28.9
14.1
3.9
4.0
mmol/l
7.37
1553
15249
188
1874
1.00
0.00
10.0
6.5
—
—
—
0
0
36
365
0.99
0.00
1.2
1.4
281.1
308.7
ug/g
0.40
23
221
52
521
1.00
0.00
2.4
1.4
—
—
—
0
0
52
521
1.00
0.00
2.4
1.4
7.4
7.4
g/l
0.04
39
401
52
521
1.00
0.00
2.4
1.4
3.7
3.9
g/l
0.47
37
384
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
1335.8
—
0
5
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
8
81
0.99
0.00
3.8
1.7
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
547.2
—
0
5
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
2.6
—
3.8
—
0
8
0
7
0.00
0.00
0.0
1.1
—
7.8
—
0
7
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
20
200
1.00
0.00
1.3
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
5.2
—
409.2
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_BRAIN_EXALLC – Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)
GWS hits: 4
This endpoint is excluded (different definition than used in FinnGen).